Low cellular PC levels have been shown to activate sterol regulatory element-binding protein-1 (SREBP1), a transcription factor involved in glucose metabolism, thereby contribute to the development of obesity, insulin resistance and fatty liver disease33. This evidence concerns the gene SREBF1 and Insulin resistance.